Mesoblast Ltd
F:LWBA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mesoblast Ltd
F:LWBA
|
AU |
|
I
|
Illumina Inc
XBER:ILU
|
US |
|
W
|
Watsco Inc
XMUN:WC3
|
US |
|
T
|
Toyota Motor Corp
SGX:N6FD
|
JP |
|
P
|
Patterson-UTI Energy Inc
XMUN:PE1
|
US |
|
P
|
Patterson Companies Inc
SWB:PD2
|
US |
|
Peet Ltd
ASX:PPC
|
AU |
|
V
|
Virgin Money UK PLC
ASX:VUK
|
UK |
|
R
|
Rhoen Klinikum AG
XBER:RHK
|
DE |
|
L
|
Lucara Diamond Corp
STO:LUC
|
CA |
|
M P Evans Group PLC
F:NYP
|
UK |
|
V
|
Valley National Bancorp
F:VNB
|
US |
|
AVZ Minerals Ltd
ASX:AVZ
|
AU |
|
P
|
Pilgrims Pride Corp
XBER:6PP
|
US |
|
T
|
Teck Resources Ltd
XBER:TEKB
|
CA |
|
K
|
Konami Group Corp
XMUN:KOA
|
JP |
|
Naver Corp
KRX:035420
|
KR |
|
G
|
Gazprom Neft' PAO
XBER:SCF
|
RU |
|
Cogent Communications Holdings Inc
NASDAQ:CCOI
|
US |
|
Q
|
Q2 Holdings Inc
F:0Q2
|
US |
|
H
|
Healius Ltd
F:PGZ
|
AU |
|
C
|
Contec Co Ltd
KOSDAQ:451760
|
KR |
|
Elior Group SA
OTC:ELORY
|
FR |
|
Sparebank 1 SR Bank ASA
LSE:0Q57
|
NO |
Bankruptcy Probability
Mesoblast Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mesoblast Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Mesoblast Ltd
ASX:MSB
|
2.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
447.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
193.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
158.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mesoblast Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mesoblast Ltd has total debt of 66m USD. This includes both short-term (0 USD) and long-term (66m USD) debt.
You can find a full breakdown on its Balance Sheet.
